Recent Posts
- Paul Carlier, Chair of the VaDDC, Receives Grant to Study Promising Antimalarial Drugs
- Norwegian researchers have shown that a phosphatase (PRL-3) inhibitor developed by VaDDC Exec. Comm. member John Lazo might be useful to treat cancer
- Webster Santos, Virginia Tech drug researcher receives $2.2 million NIH grant to further develop “fat burning” molecule
- VaDDC Executive Committee Member, Beth Sharlow Receives Promotion at UVA
- Virginia Company, Phlow Corp. Awarded $354 million to Produce Ingredients for Covid-19 Drugs